Scandinavian Real Heart AB (OSTO:HEART) Research & Development: kr0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:HEART Scandinavian Real Heart AB OSTO:HEART
31 GF Score
Price kr19.90
! 4 Warning Signs
View Full Analysis

What is Scandinavian Real Heart AB Research & Development?

Scandinavian Real Heart AB OSTO:HEART -2.93% 31 Research & Development is kr0.00 Mil as of Dec. 2025. GuruFocus rates OSTO:HEART with a GF Score™ of 31/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Scandinavian Real Heart AB's Research & Development for the six months ended in Dec. 2025 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was kr0.00 Mil.

Scandinavian Real Heart AB  (OSTO:HEART) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Scandinavian Real Heart AB Research & Development Related Terms

Scandinavian Real Heart AB Research & Development Historical Data

* Premium members only.

The historical data trend for Scandinavian Real Heart AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scandinavian Real Heart AB Research & Development Chart

Scandinavian Real Heart AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Scandinavian Real Heart AB Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:HEART
31GF Score
Scandinavian Real Heart AB OSTO:HEART
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scandinavian Real Heart AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of kr0.00 Mil mean?
Scandinavian Real Heart AB (OSTO:HEART) has a Research & Development of kr0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Scandinavian Real Heart AB and its competitors.
Is Scandinavian Real Heart AB's Research & Development too high?
Scandinavian Real Heart AB's current Research & Development is kr0.00 Mil. Overall, Scandinavian Real Heart AB has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Scandinavian Real Heart AB's Research & Development compare to ABT and SYK?
Scandinavian Real Heart AB's Research & Development of kr0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Scandinavian Real Heart AB and its competitors. Scandinavian Real Heart AB's current Research & Development is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scandinavian Real Heart AB stock overvalued right now?
Scandinavian Real Heart AB (OSTO:HEART) has a current Research & Development of kr0.00 Mil. The current Research & Development is kr0.00 Mil. Scandinavian Real Heart AB's overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Scandinavian Real Heart AB (OSTO:HEART), the current Research & Development is kr0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scandinavian Real Heart AB Business Description

Other Exchanges 7820:Germany
Address Kopparbergsvagen 6, Vasteras, SWE, 722 13
Scandinavian Real Heart AB is engaged in developing an artificial heart that mimics the shape, function, and bloodflow pattern of the human heart. The company conducts research and development in medical technology and is developing an artificial heart that mimics the function of a natural heart - a so-called total artificial heart (TAH), Realhear, TAH. It is a Swedish-patented product that saves lives and improves the quality of life.
31GF Score

Get the complete analysis for OSTO:HEART

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr19.90
Price